Serum interleukin-5 in aspirin-induced asthma

Clinical and Experimental Allergy

Volumn 31, Issue 7, 2001, Pages 1036-1040

  Mastalerz, L ^a   Sanak, M ^a   Szczeklik, Andrzej ^a,b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b NONE   (Poland)

Author keywords

Aspirin induced asthma; Cysteinyl leukotrienes; Iinterleukin 5

Indexed keywords

ACETYLSALICYLIC ACID; AMINOPHYLLINE; ANTIHISTAMINIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; INTERLEUKIN 5; LEUKOTRIENE E4; PEPTIDOLEUKOTRIENE; STEROID;

ADULT; AIRWAY; ALLERGIC ASTHMA; ARTICLE; BRONCHUS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FATTY ACID SYNTHESIS; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TISSUE LEVEL; URINE LEVEL;

ADULT; ASPIRIN; ASTHMA; CYSTEINE; FEMALE; HUMANS; INTERLEUKIN-5; LEUKOTRIENES; MALE; MIDDLE AGED;

EID: 0034818882     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2001.01105.x     Document Type: Article

References (25)

1. Identification of a lymphokine that stimulates eosinophil differentiation in vitro: Its relationship to interleukin-3 and functional properties of eosinophils produced in cultures
2. Recombinant human interleukin-5 is a selective activator of human eosinophil function
3. Asthma and inflammation
4. Interleukin-5 and allergic inflammation
5. The inflammation-repair cycle in asthma: The pivotal role of the airway epithelium
6. 4 in response to soluble agonists
7. IL-5 increases expression of 5-lipoxygenase-activating protein and translocates 5-lipoxygenase to the nucleus in human blood eosinophils
8. Nasal secretions in response to acetylsalicylic acid
9. Aspirin-induced asthma: Advances in pathogenesis and management
10. 4S) expression in blood eosinophils of patients with asthma
11. 4 synthese due to overactive transcription of an allelic variant associated with aspirin-induced asthma
12. 4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma
13. Bronchial aspirin challenge causes specific eicosanoids response in aspirin sensitive asthmatics
14. 4 in humans
15. 4 synthase promoter polymorphism and risk of aspirin-induced asthma
16. Serum interleukin-5 concentrations in atopic and non-atopic patients with glucocorticoid-dependent chronic severe asthma
17. Serum levels of eosinophil cationic protein and IL-5 in patients with asthma without systemic corticosteroids
18. T cell subsets and their soluble products regulate eosinophilia in allergic and non-allergic asthma
19. 4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5
20. Interleukin-4,-5,-6 and tumor necrosis factor-α in normal and asthmatic airways: Evidence for the human mast cell as a source of these cytokines
21. Allergen-induced proliferation and interleukin-5 production by bronchoalveolar lavage and blood T cells after segmental allergen challenge
22. Peripheral blood T lymphocytes from asthmatic patients are primed for enhanced expression of interleukin (IL-4) and IL-5 mRNA: Associations with lung function and serum IgE
23. Expression of interleukin-5 and granulocyte-macrophage colony-stimulating factor in aspirin-sensitive andnon-aspirin-sensitive asthmatic airways
24. 4 synthase dose not correlated with the aspirin-intolerant asthma phenotype in the United States
25. Measurements of leukotrienes in urine: Strategies and applications